Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Dynavax Technologies
(NQ:
DVAX
)
11.11
-0.17 (-1.51%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Dynavax Technologies
< Previous
1
2
3
4
5
Next >
Why Dynavax Technologies Stock Is Soaring Today
September 22, 2021
A COVID-19 vaccine candidate that employs the company's adjuvant technology produced positive clinical trial results.
Via
The Motley Fool
Exposures
COVID-19
Why Are Dynavax Technologies Shares Skyrocketing Today?
September 22, 2021
Clover Biopharmaceuticals has reported positive data for their COVID-19 vaccine candidate, SCB-2019, which achieved the primary and secondary efficacy endpoints in...
Via
Benzinga
Exposures
COVID-19
32 Stocks Moving In Wednesday's Mid-Day Session
September 22, 2021
Gainers Marin Software Incorporated (NASDAQ: MRIN) shares climbed 53.1% to $8.71 following an announcement from management that the company entered into a revenue share...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
September 13, 2021
Gainers Itamar Medical (NASDAQ:ITMR) shares increased by 46.58% to $30.25 during Monday's regular session. Trading volume for Itamar Medical's stock is 2.6 million...
Via
Benzinga
72 Biggest Movers From Yesterday
September 14, 2021
Gainers aTyr Pharma, Inc. (NASDAQ: LIFE) jumped 67% to settle at $9.15 on Monday as the company announced positive results from its Phase 1b/2a trial evaluating its lead...
Via
Benzinga
45 Stocks Moving In Monday's Mid-Day Session
September 13, 2021
Gainers Aterian, Inc. (NASDAQ: ATER) jumped 54.1% to $18.18. Investor presentation released on Friday is now circulating on news outlets. Itamar Medical Ltd. (NASDAQ: ITMR)...
Via
Benzinga
Why Dynavax Technologies Stock Is Sinking Today
September 13, 2021
A lost supply agreement for a partner's COVID-19 vaccine is hurting the biotech's shares today.
Via
The Motley Fool
Exposures
COVID-19
Why Dynavax Shares Are Trading Lower Today
September 13, 2021
Dynavax Technologies Corp (NASDAQ: DVAX) is trading lower after the company announced Valneva SE (NASDAQ: VALN) received a termination notice from the United Kingdom...
Via
Benzinga
Cramer Weighs In On Hut 8 Mining Corp, Ping Identity Holding And More
September 13, 2021
On CNBC's "Mad Money Lightning Round," Jim Cramer advised a viewer to buy some Ethereum instead of Hut 8 Mining Corp (NASDAQ: HUT). Cramer likes Dynavax Technologies...
Via
Benzinga
Valneva Shares Plunge As UK Terminates COVID-19 Vaccine Contract: What You Need Know
September 13, 2021
The U.K. government has terminated its COVID-19 vaccine contract with Valneva SE (NASDAQ: VALN) over alleged breach of obligations. Related Content: ...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 13, 2021
Gainers Itamar Medical (NASDAQ:ITMR) shares moved upwards by 44.37% to $29.8 during Monday's pre-market session. The market value of their outstanding shares is at $...
Via
Benzinga
21 Stocks Moving in Monday's Pre-Market Session
September 13, 2021
Gainers Itamar Medical Ltd. (NASDAQ: ITMR) rose 43% to $29.52 in pre-market trading. Zoll Medical said it has signed an agreement to acquire Itamar Medical for $31 per ADS in...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
September 07, 2021
Gainers Cellectar Biosciences (NASDAQ:CLRB
Via
Benzinga
The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week
September 05, 2021
Biotech stocks extended their gains in the week ending Sept. 3, partly aided by the broader market strength. The news flow was fairly light ahead of the Labor Day holiday...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 03, 2021
Gainers Cellect Biotechnology (NASDAQ:APOP) shares rose 68.9% to $9.29 during Friday's pre-market session. The company's market cap stands at $36.4 million....
Via
Benzinga
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
September 02, 2021
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 02, 2021
Gainers Innate Pharma (NASDAQ:IPHA) shares rose 18.22% to $4.28 during Thursday's regular session. As of 12:30 EST, this security is trading at a volume of 20.8...
Via
Benzinga
21 Stocks Moving in Wednesday's Pre-Market Session
September 01, 2021
Gainers GBS Inc. (NASDAQ: GBS) rose 72.3% to $5.58 in pre-market trading. The company markets saliva test for diabetes management and previously announced collaboration on covid-...
Via
Benzinga
The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab
September 02, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...
Via
Benzinga
Exposures
COVID-19
Product Safety
Why Dynavax Stock Is Skyrocketing 45.8% This Week
August 27, 2021
One of the company's partners launched its COVID-19 vaccine in Taiwan.
Via
The Motley Fool
Exposures
COVID-19
The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering
September 01, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...
Via
Benzinga
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
August 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical
August 31, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
August 25, 2021
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Why Coronavirus Stock Dynavax Crushed It Today
August 23, 2021
There was some very good news on the authorization front for the company.
Via
The Motley Fool
Exposures
COVID-19
Powered By Dynavax Adjuvant, Medigen COVID-19 Vaccine Launched In Taiwan
August 23, 2021
Medigen Vaccine Biologics Corporation and Dynavax Technologies Corporation (NASDAQ: DVAX) announced the rollout of their COVID-19 vaccine, MVC-COV1901, in...
Via
Benzinga
Exposures
COVID-19
60 Biggest Movers From Yesterday
August 24, 2021
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...
Via
Benzinga
Valneva Initiates Rolling Submission For COVID19 Vaccine Candidate In UK
August 23, 2021
Valneva SE (NASDAQ: VALN) has commenced rolling submission for its COVID-19 vaccine candidate with the Medicines and Healthcare products Regulatory Agency (MHRA)...
Via
Benzinga
Exposures
COVID-19
Return on Capital Employed Overview: Dynavax Technologies
August 20, 2021
Pulled from Benzinga Pro data Dynavax Technologies (NASDAQ:DVAX) posted Q2 earnings of $9.17 million, an increase from Q1 of 67.85%. Sales dropped to $52.77 million, a 36.68%...
Via
Benzinga
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.